Mentions
Extended reach
Total likes
Video views
AI synopsis
Several posts summarize the research, such as highlighting how PDE5 inhibitors may boost estrogen synthesis in bones through the cGMP/PKG pathway, using keywords like 'promotes' and 'new role.' The tone remains neutral and informative, reflecting moderate interest without extensive debate or critique.
Most contributions align with the article's findings, recognizing the significance of PDE5 inhibition in promoting bone health.
Discussions show moderate curiosity about the biological pathways and potential applications, but lack passionate enthusiasm.
Participants briefly reference mechanisms like cGMP/PKG/SHP2 but do not delve deeply into technical details or broader implications.
The discussions acknowledge the importance of the research in advancing osteoporosis treatments but remain somewhat general without substantial influence on practice or policy.
New Research: Inhibition of Phosphodiesterase 5 Promotes the Aromatase-Mediated Estrogen Biosynthesis in Osteoblastic Cells by Activation of cGMP/PKG/SHP2 Pathway: Mechanical stimulation induces bone growth and remodeling by the… https://t.co/56hokFJbVQ #Endocrinology #Endo
Studies discuss that inhibition of phosphodiesterase 5 raises cGMP levels, activating PKG and SHP2, which promotes estrogen production and osteoblast differentiation, offering potential strategies for osteoporosis…
This video discusses how PDE5 inhibition raises cGMP levels, activating pathways that boost aromatase activity and estrogen synthesis in osteoblasts, which may help treat osteoporosis.
New Research: Inhibition of Phosphodiesterase 5 Promotes the Aromatase-Mediated Estrogen Biosynthesis in Osteoblastic Cells by Activation of cGMP/PKG/SHP2 Pathway: Mechanical stimulation induces bone growth and remodeling by the… https://t.co/56hokFJbVQ #Endocrinology #Endo
FE